Showing posts with label Global Advanced Wound Care Market. Show all posts
Showing posts with label Global Advanced Wound Care Market. Show all posts
Global Advanced Wound Care Market by 2024 Leading Countries, Growth, Drivers, Risks, Opportunities, Forecast & Top Vendors Analysis

Global Advanced Wound Care Market by 2024 Leading Countries, Growth, Drivers, Risks, Opportunities, Forecast & Top Vendors Analysis


Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2024


Global Advanced Wound Care Market is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

This report consists of below pages:

             No of pages: 403
             No of Figures: 24
             No of Tables: 434


Acelity L.P. INC. is going to dominate the advanced wound care market in 2016 followed by Smith and Nephew, and Mölnlycke Health Care. Other players in this market include 3M, Medtronic, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical among others holds 26.0% of the global advanced wound care market in 2016.

ACELITY L.P. INC.:

Acelity L.P. Inc was founded in 1976 and headquartered in San Antonio, Texas; this company designs products to address needs in the areas of advanced wound therapy and regenerative medicine with best-in-class solutions that deliver superior clinical outcomes for patients. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Acelity L.P. Inc operates through two business segments: Advanced Wound Therapy (AWT) and Regenerative Medicine (RM).

Recent Developments:

1.       In February 2017, Acelity L.P. Inc. announced that it has completed the sale of its regenerative medicine business unit, Life cell Ccorporation to Allergen for USD 2.9 billion in cash.

2.        In October 2016, Acelity L.P. Inc. announced that Alloderm Select Duo Regenerative Tissue Matrix is launched in the United States. Alloderm Regenerative Tissue Matrix is the nation’s leading biological tissue matrix for soft tissue reinforcement.


SMITH AND NEPHEW:

Company supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Smith and Nephew operate through four business segments: orthopedics reconstruction, advanced wound management, sports medicine, and trauma & extremities.

Recent Developments:

3.       In December 2016, Smith and Nephew, the globalmedical technology business, has been awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system.

MOLNLYCKE HEALTHCARE:

Molnlycke was founded in 1849, and is headquartered in Gothenburg, Sweden. Mölnlycke Health Care is a world leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. Company design and supply products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world.

Recent Developments:

1.       In February 2016, Molnlycke announced the acquisition of Sundance Solutions, a leader in developing innovative solutions for the safe positioning and turning of patients to help prevent pressure ulcers.


TABLE OF CONTENTS:

1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
7. GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE
8. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER
9. GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
10. GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET
10.3. APAC ADVANCED WOUND CARE MARKET
10.5. EUROPE ADVANCED WOUND CARE MARKET
10.6. MEA ADVANCED WOUND CARE MARKET
11. GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA
12. COMPANY PROFILES
12.1. ACELITY L.P. INC.
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTHCARE
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLI
12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTF
12.4.4. RECENT DEVELOPMENTS
12.5. 3M
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. BAXTER
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. COLOPLAST
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. INTEGRA LIFE SCIENCES CORPORATION
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. DERMA SCIENCES INC
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. RECENT DEVELOPMENTS
12.11. PAUL HARTMANN LIMITED
12.11.1. COMPANY OVERVIEW
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.12. ORGANOGENESIS INC
12.12.1. COMPANY OVERVIEW
12.12.2. REVENUE ANALYSIS
12.12.3. PRODUCT PORTFOLIO
12.12.4. RECENT DEVELOPMENTS

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024


About Data Bridge Market Research:


Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818

Global Advanced Wound Care Market Technology Progress 2018-2024


The new report titled "Global Advanced Wound Care Market" is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), By Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), By End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), By Distribution Channel (Direct Tenders Public, Retail Private), By Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) and Forecast to 2024.


Acelity L.P. INC. is going to dominate the advanced wound care market in 2016 followed by Smith and Nephew, and Mölnlycke Health Care. Other players in this market include 3M, Medtronic, Convatec Inc, Baxter, Coloplast, Ethicon. Inc, Hollister Inc, Integra Life Sciences Corporation, Derma Sciences Inc, Spiracur Inc, Medline Industries, Mimedx Group, Organogenesis Inc, Talley Group, BSN Medical, Devon Medical Products, Human Biosciences Inc, B.Braun Melsungen AG, Cardinal Health, Paul Hartmann Limited, DeRoyal Industries Inc, DermaRite Industries LLC, MPM Medical Inc, Kinetic Concepts, Advancis Medical among others holds 26.0% of the global advanced wound care market in 2016.

Key Drivers: 


Some of the major factors driving the growth of advanced wound care market are technological advancement, rising incidences of chronic wound, government support, rising geriatric population, and increasing trend.
  • Increasing prevalence of chronic diseases can be related to lifestyle, such as diabetes and obesity, are one of the fundamental trends which are driving growth of advanced wound care market.
  • The increasing prevalence of chronic wounds is driving demand for products which enhance quality of life and limit the risk of more serious health problems
  • Willingsford Healthcare a small British company is to receive government grant to develop its innovative wound treatment.
  • Advance wound care is highly used in case of pressure ulcers, diabetic ulcers and chronic ulcers.


ACELITY L.P. INC.:

Acelity L.P. Inc was founded in 1976 and headquartered in San Antonio, Texas; this company designs products to address needs in the areas of advanced wound therapy and regenerative medicine with best-in-class solutions that deliver superior clinical outcomes for patients. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Acelity L.P. Inc operates through two business segments: Advanced Wound Therapy (AWT) and Regenerative Medicine (RM).

Recent Developments:

1.       In February 2017, Acelity L.P. Inc. announced that it has completed the sale of its regenerative medicine business unit, Life cell Ccorporation to Allergen for USD 2.9 billion in cash.

2.        In October 2016, Acelity L.P. Inc. announced that Alloderm Select Duo Regenerative Tissue Matrix is launched in the United States. Alloderm Regenerative Tissue Matrix is the nation’s leading biological tissue matrix for soft tissue reinforcement.


SMITH AND NEPHEW:

Company supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world. Smith and Nephew operate through four business segments: orthopedics reconstruction, advanced wound management, sports medicine, and trauma & extremities.

Recent Developments:

3.       In December 2016, Smith and Nephew, the globalmedical technology business, has been awarded the 2016 French Galien Award for PICO; the novel single-use negative pressure wound therapy (NPWT) system.

MOLNLYCKE HEALTHCARE:

Molnlycke was founded in 1849, and is headquartered in Gothenburg, Sweden. Mölnlycke Health Care is a world leading medical products and solutions company that equips healthcare professionals to achieve the best patient, clinical and economic outcomes. Company design and supply products and solutions for use in wound treatment, pressure ulcer, infection prevention and surgery. The company's operations span across North America, Europe, Middle East, Africa, Asia, and rest of the world.

Recent Developments:

1.       In February 2016, Molnlycke announced the acquisition of Sundance Solutions, a leader in developing innovative solutions for the safe positioning and turning of patients to help prevent pressure ulcers.

This report consists of below pages:


•             No of pages: 403
•             No of Figures: 24
•             No of Tables: 434



TABLE OF CONTENTS:

1. INTRODUCTION

1.1. OVERVIEW OF GLOBAL ADVANCED WOUND CARE MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING AGING AND GERIATRIC POPULATION
3.1.2. TECHNOLOGICAL ADVANCEMENT
3.1.3. GOVERNMENT SUPPORT
3.1.4. RISING INCIDENCES OF CHRONIC WOUND
3.1.5. INCREASING TREND
3.2. RESTRAINTS
3.2.1. LOW AWARENESS
3.2.2. SLOW GROWTH RATE AND SHRINKING MARKET
3.2.3. COMPLEX REGULATORY APPROVAL PROCESS
3.2.4. COMPETITION WITH OTHER MOIST DRESSINGS
3.3. OPPORTUNITIES
3.3.1. REIMBURSEMENT
3.3.2. MERGERS AND ACQUISITIONS TO EXPAND BUSINESS
3.3.3. UNMET NEED
3.3.4. INCREASING DEMAN
3.4. CHALLENGE
3.4.1. SHORTAGE OF TRAINED STAFF
3.4.2. THE DEVELOPMENT OF SUBSTITUTE PRODUCTS
3.5. KEY MARKET TRENDS AND UPCOMMING TECHNOLOGIES
3.5.1. SMART DRESSING WILL PUSH FUTURE GROWTH
3.5.2. HYDROFIBER HAS BEEN THE MOST SIGNIFICANT RECENT INNOVATION
3.5.3. ALGINATE DRESSING IS EXPECTED TO GROW ROBUSTLY IN THE UPCOMING YEARS
3.5.4. FOAM DRESSING ACCOUNTING THE LARGEST MARKET SEGMENT IN THE UPCOMING YEARS
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
6.1. OVERVIEW
6.2. DRESSING
6.3. BIOLOGICS
6.4. THERAPY DEVICES
7. GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE
7.1. INTRODUCTION
7.2. SURGICAL WOUND
7.2.1. CLASS I
7.2.2. CLASS II
7.2.3. CLASS III
7.2.4. CLASS IV
7.3. DIABETIC ULCERS
7.4. PRESSURE ULCERS
7.5. VENOUS ULCERS
7.6. BURNS
8. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER
8.1. OVERVIEW
9. GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
9.1. OVERVIEW
10. GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET
10.2.1. U.S. ADVANCED WOUND CARE MARKET
10.2.2. CANADA ADVANCED WOUND CARE MARKET
10.2.3. MEXICO ADVANCED WOUND CARE MARKET
10.3. APAC ADVANCED WOUND CARE MARKET
10.3.1. JAPAN ADVANCED WOUND CARE MARKET
10.3.2. CHINA ADVANCED WOUND CARE MARKET
10.3.3. SOUTH KOREA ADVANVCED WOUND CARE MARKET
10.3.4. INDIA ADVANCED WOUND CARE MARKET
10.3.5. AUSTRALIA ADVANCED WOUND CARE MARKET
10.3.6. THAILAND ADVANCED WOUND CARE MARKET
10.3.7. SINGAPORE ADVANCED WOUND CARE MARKET
10.3.8. MALAYSIA ADVANVCED WOUND CARE MARKET
10.3.9. PHILIPPINESADVANCED WOUND CARE MARKET
10.3.10. INDONESIA ADVANCED WOUND CARE MARKET
10.3.11. REST OF APAC ADVANCE WOUND CARE MARKET
10.4. SOUTH AMERICA ADVANCED WOUND CARE MARKET
10.4.1. BRAZIL ADVANCED WOUND CARE MARKET
10.4.2. REST OF SOUTH AMERICA ADVANCED WOUND CARE MARKET
10.5. EUROPE ADVANCED WOUND CARE MARKET
10.5.1. GERMANY ADVANCED WOUND CARE MARKET
10.5.2. FRANCE ADVANCED WOUND CARE MARKET
10.5.3. U.K. ADVANCED WOUND CARE MARKET
10.5.4. ITALY ADVANCED WOUND CARE MARKET
10.5.5. SPAIN ADVANCED WOUND CARE MARKET
10.5.6. SWITZERLAND ADVANCED WOUND CARE MARKET
10.5.7. NETHERLANDS ADVANCED WOUND CARE MARKET
10.5.8. RUSSIA ADVANCED WOUND CARE MARKET
10.5.9. BELGIUM ADVANCED WOUND CARE MARKET
10.5.10. TURKEY ADVANCED WOUND CARE MARKET
10.5.11. REST OF EUROPE ADVANCED WOUND CARE MARKET
10.6. MEA ADVANCED WOUND CARE MARKET
10.6.1. SOUTH AFRICA ADVANCED WOUND CARE MARKET
10.6.2. SAUDI ARABIA ADVANCED WOUND CARE MARKET
10.6.3. UAE ADVANCED WOUND CARE MARKET
10.6.4. REST OF MEA ADVANCED WOUND CARE MARKET
11. GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA
12. COMPANY PROFILES
12.1. ACELITY L.P. INC.
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. SMITH AND NEPHEW
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. MOLNLYCKE HEALTHCARE
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLI
12.3.4. RECENT DEVELOPMENTS
12.4. CONVATEC INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTF
12.4.4. RECENT DEVELOPMENTS
12.5. 3M
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
12.6. BAXTER
12.6.1. COMPANY OVERVIEW
12.6.2. REVENUE ANALYSIS
12.6.3. PRODUCT PORTFOLIO
12.6.4. RECENT DEVELOPMENTS
12.7. COLOPLAST
12.7.1. COMPANY OVERVIEW
12.7.2. REVENUE ANALYSIS
12.7.3. PRODUCT PORTFOLIO
12.7.4. RECENT DEVELOPMENTS
12.8. ETHICON INC
12.8.1. COMPANY OVERVIEW
12.8.2. REVENUE ANALYSIS
12.8.3. PRODUCT PORTFOLIO
12.8.4. RECENT DEVELOPMENTS
12.9. INTEGRA LIFE SCIENCES CORPORATION
12.9.1. COMPANY OVERVIEW
12.9.2. REVENUE ANALYSIS
12.9.3. PRODUCT PORTFOLIO
12.9.4. RECENT DEVELOPMENTS
12.10. DERMA SCIENCES INC
12.10.1. COMPANY OVERVIEW
12.10.2. REVENUE ANALYSIS
12.10.3. PRODUCT PORTFOLIO
12.10.4. RECENT DEVELOPMENTS
12.11. PAUL HARTMANN LIMITED
12.11.1. COMPANY OVERVIEW
12.11.2. REVENUE ANALYSIS
12.11.3. PRODUCT PORTFOLIO
12.12. ORGANOGENESIS INC
12.12.1. COMPANY OVERVIEW
12.12.2. REVENUE ANALYSIS
12.12.3. PRODUCT PORTFOLIO
12.12.4. RECENT DEVELOPMENTS

Related Report

Global Tumour Ablation Market – Trends and Forecast to 2024

Global Tumour Ablation Market, By Type (Tumour Ablation Systems (Radio Frequency Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain, Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics, Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest of the World) – Trends and Forecast to 2024


About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get 10% Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.


Contact:

Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818

Advanced Wound Care Market Size, Share, Growth Rate, Trends and Forecast, 2017-2024

This report scope includes a holistic study of the current dynamics of the market, industry growth and restraints of the market. It provides the market forecast to 2024, recent developments in the market and pipeline analysis of the major players. The report also includes a review of micro and macro forecasts, new entrant strategies, and market penetration strategies with a comprehensive value chain analysis.


Global Advanced Wound Care Market research report is expected to reach USD 22,088.6 million by 2024 from USD 11,683.5 million in 2016, at a CAGR of 8.4% in the forecast period 2017 to 2024.

Global Advanced Wound Care Market, By Type (Dressings, Biologics, Therapy Devices), Wound Type (Surgical Wounds, Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Burns, Other Traumatic Wounds), End Users (Hospitals, Wound Care Centers, Ambulatory Centers, Clinics, Community Healthcare, Home Healthcare), Distribution Channel (Direct Tenders Public, Retail Private), Geography (North America, Europe, Asia Pacific, South America, Middle East and Africa) and Forecast to 2024
Key Players Mentioned:

·         3M
·         Smith and Nephew
·         Medtronic
·         Acelity L.P. INC
·         Molnlycke Healthcare AB
·         Convatec Inc
·         Baxter
·         Coloplast
·         Ethicon. Inc
·         Hollister Inc
·         Integra Life Sciences Corporation
·         Derma Sciences Inc
·         Spiracur Inc
·         Medline Industries
·         Mimedx Group
·         Organogenesis Inc
·         Talley Group
·         BSN Medical
·         Devon Medical Products
·         Human Biosciences Inc
·         B.Braun Melsungen AG
·         Cardinal Health
·         Paul Hartmann Limited
·         DeRoyal Industries Inc
·         DermaRite Industries LLC
·         MPM Medical Inc
·         Kinetic Concepts
·         Advancis Medical


Scope of the Report:

The global advanced wound care market is segmented into three product types, dressing, biologics, and therapy devices. In 2017, dressing segment is expected to dominate the global advanced wound care market with around 51 percent market share and is expected to dominate in the forecast period 2017 to 2024. However, biologics segment is expected to grow at the highest CAGR in the forecast period.

Based on dressing type, the market is segmented into foam dressing, hydrogels, film dressings, alginates, wound contact layer and super absorbent dressing. In 2017, film dressing segment is expected to dominate the global advanced wound care market.

Based on biologics type, the market is segmented synthetic into skin grafts, growth factors, allografts and xenografts.

Based on wound care growth factor type, the market is segmented into platelet derived growth factor (PDGF), platelet rich plasma (PRP), epidermal growth factor (EGF), basic fibroblast growth factor (BFGF), granulocyte colony stimulating factor (G-CSF), talactoferrin ALFA, thrombin peptide (TP508) and keratinocyte growth factor (KGF).

Based on wound care therapy devices type, the market is segmented into negative pressure wound therapy (NPWT), pressure relief devices (PRD), wound debridement devices, hyperbaric oxygen chambers and physical therapies.

Based on NPWT type, the market is segmented into stand-alone NPWT devices, portable NPWT devices and disposable NPWT devices.

Based on PRD type, the market is segmented into mattress and bed.

Based on hyperbaric oxygen chambers type, the market is segmented into monoplace, multiplace and topical.

Based on wound debridement devices type, the market is segmented into hydrosurgical, ultrasound, and mechanical among others.

Based on physical therapies type, the market is segmented into laser therapy, electrical simulation, external shock wave therapies and saline mist therapy.

Based on wound type, the market is segmented into surgical wound, diabetic ulcer, burns, pressure ulcer, and venous ulcer among others. Diabetic ulcers segment is expected to grow at the highest CAGR of in the forecast period.

On the basis of end users, the market is classified into hospitals, wound care centers, ambulatory centers, home healthcare, clinics, and community healthcare. In 2017, hospitals segment is expected to dominate the global advanced wound care market and is expected to dominate in the forecast period 2017 to 2024.

On the basis of distribution channel the market is segmented into direct tenders, and retails.


Key Topics Covered:

1. INTRODUCTION
2. MARKET SEGMENTATION
3. MARKET OVERVIEW
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. GLOBAL ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE
7. GLOBAL ADVANCED WOUND CARE MARKET, BY WOUND TYPE
8. GLOBAL ADVANCED WOUND CARE MARKET, BY END USER
8.1. OVERVIEW
9. GLOBAL ADVANCED WOUND CARE MARKET, BY DISTRIBUTION CHANNEL
10. GLOBAL ADVANCED WOUND CARE MARKET, BY GEOGRAPHY
10.1. OVERVIEW
10.2. NORTH AMERICA ADVANCED WOUND CARE MARKET
10.3. APAC ADVANCED WOUND CARE MARKET
10.4. SOUTH AMERICA ADVANCED WOUND CARE MARKET
10.5. EUROPE ADVANCED WOUND CARE MARKET
10.6. MEA ADVANCED WOUND CARE MARKET
11. GLOBAL ADVANCED WOUND CARE MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL
11.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
11.3. COMPANY SHARE ANALYSIS: EUROPE
11.4. COMPANY SHARE ANALYSIS: ASIA-PACIFIC (APAC)
11.5. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA (MEA)
11.6. COMPANY SHARE ANALYSIS: SOUTH AMERICA
12. COMPANY PROFILES
12.1. ACELITY L.P. INC.
12.2. SMITH AND NEPHEW
12.3. MOLNLYCKE HEALTHCARE
12.4. CONVATEC INC.
12.5. 3M
12.6. BAXTER
12.7. COLOPLAST
12.8. ETHICON INC
12.9. INTEGRA LIFE SCIENCES CORPORATION
12.10. DERMA SCIENCES INC
12.11. PAUL HARTMANN LIMITED
12.12. ORGANOGENESIS INC
13. RELATED REPORTS

Related Report

Global Active Wound Care Market – Industry Trends and Forecast to 2024

Global Active Wound Care Market By Product Type (Allograft, Synthetic Skin Grafts, Xenografts, Collagen Dressings, Amniotic Tissue Grafts, Growth Factors (Platelet Derived Growth Factor (PDGF), Platelet Rich Plasma (PRP), Epidermal Growth Factors (EGF), Basic Fibroblast Growth Factors (BFGF), Granulocyte Colony Stimulating Factor     (G-CSF), Talactoferrin ALFA, Thrombin Peptide, and Keratinocyte Growth Factor (KGF)), By Distribution Channel, By End Users, By Indication, Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024


About Data Bridge Market Research:   
                      
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:
Vishal Dixit
Data Bridge Market Research
Tel: +1-888-387-2818

Powered by Blogger.